We present the draft genome sequences of eight uropathogenic strains of Escherichia coli isolated from blood cultures collected from patients with sepsis, an extension of previous sequencing work from the same cohort.
genic Escherichia coli isolated from the blood of patients admitted to the UC Davis Medical Center with sepsis from a urinary tract source of infection (1) . Here we report on the genomes of an additional eight strains isolated from unique patients in this study. All aspects of the study were approved by the institutional review board of the UC Davis Medical Center (Protocol #247849).
Sepsis is the costliest reason for hospitalization in the United States, affecting more than 1.6 million Americans each year (2, 3) . Severe sepsis and septic shock carry a high risk of in-hospital mortality (4, 5) but clinical outcomes vary widely across individuals. One goal of this sequencing effort is to begin to tease out the relative contributions of pathogen genomic variability and host susceptibility factors to clinical outcomes.
Strains of E. coli were isolated from overnight plated subcultures of initial liquid blood cultures obtained in the course of routine clinical practice and stored in an Ϫ80°C biorepository. A single colony from each strain was grown in LB broth at 37°C, then used for genomic DNA extraction. Illumina paired-end libraries were made from E. coli genomic DNA extracted using an Mo Bio Powersoil DNA extraction kit (Mo Bio, Carlsbad, CA). Libraries were prepared using an Illumina TruSeq Kit (Illumina, San Diego, CA). The samples were pooled together and then sequenced on an Illumina MiSeq for paired-end 250-bp reads.
An average of 4,042,576 paired-end reads per sample were generated. Quality trimming and error correction resulted in an average of 3,838,940 high-quality reads. All sequence processing and assembly of the Illumina reads were performed using the A5 assembly pipeline (6) . Automated annotation was performed using the RAST annotation server (7) . The assembly and annotation statistics are presented in Table 1 .
Nucleotide sequence accession numbers. All 8 assemblies described in this paper have been deposited as whole-genome shotgun projects in DDBJ/EMBL/GenBank under the accession numbers provided in Table 1 .
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